I was chatting with friends recently about COVID-19 vaccine stocks to buy like Moderna, Pfizer and the other big drug companies.
And they all had the same basic questions:
So is it too late to buy COVID-19 vaccine stocks?
The short answer is… no. But you have to weigh your options, particularly when it comes to risk vs. reward.
A few months ago I made my first foray in shares of Moderna Inc. (Nasdaq: MRNA). The company saw another big pop Monday while the rest of the stock market was down… and then everything was up Tuesday morning.
Moderna’s vaccine has been shown to be 94% effective in preventing COVID-19. The company requested emergency clearance from the Food and Drug Administration on Monday. I originally thought I missed the boat on this COVID-19 vaccine stock, but I’m now up 110-plus percent.
Moderna was up to $172 a share by Tuesday morning. Could it continue to move higher? It can and I think it will. How much higher is up for debate after it’s already gone up 150% the past month. (Check out my short video below where I go more in-depth on Moderna’s outlook.)
There are still plenty of opportunities. But we have to expand our field of view a bit in terms of risk vs. reward.
So what about Pfizer Inc. (NYSE: PFE) or AstraZeneca PLC (Nasdaq: AZN), a couple of other major players on the vaccine front?
If you want to double your money in a speculative position in just a year or two, avoid these two…
Sure, they’re both great companies. But they are already huge firms with billions of dollars in profits and revenue. So you’re not going to get the same bang for your buck as you will with more speculative plays. You don’t have the same degree of risk, either. But that’s the trade-off when it comes to risk vs. reward.
Check out my short video and let’s discuss a handful of speculative COVID-19 vaccine stocks that offer more risk — and far more reward. Then share your thoughts in the comments below.
P.S. Don’t Miss Out on the Next Big Gold Boom
This has been a banner year for precious metals and the next gold rally is already in full swing, with big profits flowing to those who play their cards right.
Unfortunately, most people don’t understand how to make quick returns off of these slow-moving gold trends.
So they sit in “buy and hold” gold strategies that take years to play out… while in-the-know investors collect their gains week after week.
Be an in-the-know investor, not a buy-and-holder.
Instead, learn how to take advantage of commodity rallies like gold while they’re still in their early innings.